company background image
300957 logo

Yunnan Botanee Bio-Technology GroupLTD SZSE:300957 Stock Report

Last Price

CN¥52.72

Market Cap

CN¥22.1b

7D

-3.6%

1Y

-40.6%

Updated

18 Oct, 2024

Data

Company Financials +

Yunnan Botanee Bio-Technology Group Co.LTD

SZSE:300957 Stock Report

Market Cap: CN¥22.1b

Yunnan Botanee Bio-Technology Group Co.LTD Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Yunnan Botanee Bio-Technology GroupLTD
Historical stock prices
Current Share PriceCN¥52.72
52 Week HighCN¥91.60
52 Week LowCN¥39.30
Beta0.64
11 Month Change29.09%
3 Month Change10.29%
1 Year Change-40.56%
33 Year Change-76.81%
5 Year Changen/a
Change since IPO-67.62%

Recent News & Updates

The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Sep 27
The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Recent updates

The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Sep 27
The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?

Sep 25
Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year

Jun 03
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year

A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)

May 24
A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)

Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 02
Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet

Feb 29
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet

Shareholder Returns

300957CN Personal ProductsCN Market
7D-3.6%-7.3%-4.4%
1Y-40.6%-17.3%0.05%

Return vs Industry: 300957 underperformed the CN Personal Products industry which returned -17.3% over the past year.

Return vs Market: 300957 underperformed the CN Market which returned 0.1% over the past year.

Price Volatility

Is 300957's price volatile compared to industry and market?
300957 volatility
300957 Average Weekly Movement11.0%
Personal Products Industry Average Movement7.1%
Market Average Movement7.5%
10% most volatile stocks in CN Market11.3%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 300957's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 300957's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20103,852Zhenyu Guowww.botanee.com.cn

Yunnan Botanee Bio-Technology Group Co LTD engages in the manufacture and sale of skincare and makeup products in China. The company offers facial creams, toners, face masks, serums, and lotions, as well as makeup products, such as sunscreens, powders, BB creams, and makeup removers.

Yunnan Botanee Bio-Technology Group Co.LTD Fundamentals Summary

How do Yunnan Botanee Bio-Technology GroupLTD's earnings and revenue compare to its market cap?
300957 fundamental statistics
Market capCN¥22.15b
Earnings (TTM)CN¥790.55m
Revenue (TTM)CN¥5.96b

28.0x

P/E Ratio

3.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300957 income statement (TTM)
RevenueCN¥5.96b
Cost of RevenueCN¥1.65b
Gross ProfitCN¥4.31b
Other ExpensesCN¥3.52b
EarningsCN¥790.55m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 25, 2024

Earnings per share (EPS)1.88
Gross Margin72.30%
Net Profit Margin13.27%
Debt/Equity Ratio9.7%

How did 300957 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

32%

Payout Ratio